Agnish Dey
Seminars
Thursday 17th September 2026
QSP Modeling to Inform Dose & Regimen Selection for TAK-280: A Bi-specific Antibody
2:00 pm
- Both QW and BIW dosing led to comparable predicted safety outcome
- Immune cell dynamics reveal the key role of de-sensitization in driving attenuation of cytokine Cmax
